Orion, Bayer prostate cancer drug gets FDA approval

Finland's Orion and Germany's Bayer said on Wednesday the U.S. Food and Drug Administration (FDA) had approved prostate cancer drug daroluramide, which the two companies have been developing together.

from Reuters: Health News https://ift.tt/2Mu4xKP
https://ift.tt/xePdMM